Copyright Notice: http://www.ncbi.nlm.nih.gov/books/about/copyright/
NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
This publication is provided for historical reference only and the information may be out of date.
Despite decades of progress, individuals from all walks of life, in urban, suburban, and rural communities, continue to use and abuse legal and illegal drugs. This report focuses on the drug treatment, medical care, and followup services needed by one special population -- pregnant, substance-using women.
Because this Treatment Improvement Protocol is particularly designed to assist drug treatment programs that receive Block Grant funding through their State substance abuse agencies, the emphasis here is on women served in the publicly funded drug treatment system. Such women are often poor and suffering from multiple socioeconomic problems. This emphasis should in no way obscure the fact that many affluent women also experience alcohol and drug problems. Those women who receive medical care through their private providers also need treatment for alcohol and other drug abuse. These guidelines are relevant to these women as well.
Contents
- What Is a TIP?
- Consensus Panel on Pregnant, Substance-Using Women
- Foreword
- Introduction
- Chapter 1—Alcohol and Other Drug Treatment Guidelines for Pregnant, Substance-Using Women
- Chapter 2—Medical Guidelines for Pregnant, Substance-Using Women
- Overview
- Guideline 8—Prenatal Intake
- Guideline 9—Prenatal Followup
- Guideline 10—Labor and Delivery for Women Who Have Received Prenatal Care
- Guideline 11—Labor and Delivery for Women With No Prenatal Care
- Guideline 12—Postpartum Care
- Guideline 13—Obstetrical Care for HIV-Infected Women
- Guideline 14—Drug-Exposed Neonates
- Guideline 15—Urine Toxicology Considerations
- Guideline 16—Nutritional Considerations
- Chapter 3—Legal and Ethical Guidelines for the Care of Pregnant, Substance-Using Women
- Appendix A—Training Guidelines for Programs
- Appendix B—Assessment Instruments
- Appendix C—Continuum of Care Model Program
- Appendix D—Quality Assurance Monitoring
- Appendix E—Glossary of Terms
- Appendix F—References
- Appendix G—Federal Resource Panel on Pregnant, Substance-Using Women
- Appendix H—Contributors
- Appendix I—Comprehensive Care Flow Charts
This publication is part of the Substance Abuse Prevention and Treatment Block Grant technical assistance program. This publication was written under contract number ADM 270-90-0001 from CSAT. Richard Bast served as the Government project officer.
The opinions expressed herein are those of the Consensus Panel members and do not reflect the official position of the Substance Abuse and Mental Health Services Administration (SAMHSA) or any other part of the U.S. Department of Health and Human Services (DHHS). No official support or endorsement of SAMHSA or DHHS is intended or should be inferred. The guidelines proffered in this document should not be considered as substitutes for individualized patient care and treatment decisions.
-
Review Prostate cancer disparities in South Carolina: early detection, special programs, and descriptive epidemiology.
[J S C Med Assoc. 2006]
Review Prostate cancer disparities in South Carolina: early detection, special programs, and descriptive epidemiology.Drake BF, Keane TE, Mosley CM, Adams SA, Elder KT, Modayil MV, Ureda JR, Hebert JR. J S C Med Assoc. 2006 Aug; 102(7):241-9.
-
Review Demographic and psychosocial characteristics of substance-abusing pregnant women.
[Clin Perinatol. 1999]
Review Demographic and psychosocial characteristics of substance-abusing pregnant women.Hans SL. Clin Perinatol. 1999 Mar; 26(1):55-74.
-
Demographic and Substance Abuse Trends Among Pregnant and Non-Pregnant Women: Eleven Years of Treatment Admission Data.
[Matern Child Health J. 2011]
Demographic and Substance Abuse Trends Among Pregnant and Non-Pregnant Women: Eleven Years of Treatment Admission Data.McCabe JE, Arndt S. Matern Child Health J. 2011 Aug 13; . Epub 2011 Aug 13.
-
Women living with drug abuse and HIV disease: drug abuse treatment access and secondary prevention issues.
[J Psychoactive Drugs. 1995]
Women living with drug abuse and HIV disease: drug abuse treatment access and secondary prevention issues.Weissman G, Melchior L, Huba G, Smereck G, Needle R, McCarthy S, Jones A, Genser S, Cottler L, Booth R. J Psychoactive Drugs. 1995 Oct-Dec; 27(4):401-11.
-
No health without mental health: A role for the cochrane collaboration.
[Cochrane Database Syst Rev. 2010]
No health without mental health: A role for the cochrane collaboration.Churchill R. Cochrane Database Syst Rev. 2010 Oct 6; 8:ED000012. Epub 2010 Oct 6.
-
Pregnant, Substance-Using Women
Pregnant, Substance-Using WomenBookshelf
-
Juvenile Polyposis Syndrome - GeneReviews™
Juvenile Polyposis Syndrome - GeneReviews™Bookshelf
-
Medication-Assisted Treatment for Opioid Addiction in Opioid Treatment Programs
Medication-Assisted Treatment for Opioid Addiction in Opioid Treatment ProgramsBookshelf
-
Von Hippel-Lindau Syndrome - GeneReviews™
Von Hippel-Lindau Syndrome - GeneReviews™Bookshelf
-
Substance Abuse Treatment: Group Therapy
Substance Abuse Treatment: Group TherapyBookshelf
Your browsing activity is empty.
Activity recording is turned off.
See more...